IMNM vs BIIB: Which Stock is Better?
Side-by-side comparison of Immunome Inc and Biogen Inc in 2026
IMNM
Immunome Inc
$22.90
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | IMNM | BIIB | Winner |
|---|---|---|---|
| Market Cap | $2.56B | $25.88B | BIIB |
| P/E Ratio | N/A | 20.09 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | -1.0% | -0.1% | BIIB |
| Gross Margin | -2454.2% | 78.9% | BIIB |
Analyze IMNM
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMNM or BIIB a better investment?
Comparing IMNM and BIIB: Immunome Inc has a market cap of $2.56B while Biogen Inc has $25.88B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMNM and BIIB?
IMNM (Immunome Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMNM or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMNM or BIIB?
BIIB has higher revenue growth at -0.1% vs -1.0% for IMNM.
Which company is more profitable: IMNM or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -2454.2% for IMNM.
Which is the larger company: IMNM or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.88B compared to $2.56B for IMNM.
Should I buy IMNM or BIIB in 2026?
Both IMNM and BIIB have investment merit. IMNM trades at $22.90 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMNM and BIIB stock?
Key differences: Market Cap ($2.56B vs $25.88B), P/E Ratio (N/A vs 20.1x), Revenue Growth (-1.0% vs -0.1%), Gross Margin (-2454.2% vs 78.9%).